RIZE ONCOLOGY INC.

General Information

Official company information

Registry ID: BC1328128
Company Age: 3 years
Registration Date: 13 October 2021
Registered Address: 301-1665 Ellis Street, Kelowna V1Y 2B3
Business Number (BN): 772513305
City: Kelowna
Status Notes: 2021-10-13
Email: [email protected]
Phone: +15147962640
Website: rizeoncology.com/

Official company website with more information about products, services, and contact details.

About RIZE ONCOLOGY INC.

Company profile and description

Rize Oncology Inc. is a clinical-stage biopharmaceutical company dedicated to the development of STS-201, a small-molecule drug with a unique mechanism of action, currently being evaluated for its potential in treating soft tissue sarcoma and other cancers. Rize Oncology aims to make a meaningful impact on patients' lives byTurning the Tide on Metastasis. The company was founded in 2018 and is based in Kelowna, Canada.

Additional Information

Detailed company information and status

Version: 1820795180593184768
Hierarchy: parent
Entity Type: BC Company
Display Date: 2021-10-13
Jurisdiction: BC
Business Number: 772513305
MRAS Entity Type: BCA

Company Contacts

Key contacts and leadership 4 total contacts

Login For More

Name & Position	Email	Contact Number	Fax Number
R Roland Boivin CEO	[email protected]	83329443631	-
D Daren Graham Executive Chairperson	[email protected]	83329443632	-
J James O'Neill Chief Financial Officer	-	-	-
J John Rothman Chief Scientific Officer	-	-	-